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Restorative proctocolectomy with ileal pouch-anal anastomosis (RPC-IPAA) is 
a surgical procedure performed when excising the entire colon and rectum is need 
and reconstitution of the intestinal transit through an ileal pouch is made with 
anastomosis to the anus. It is mainly used to treat patients with familial adeno-
matous polyposis (FAP) and ulcerative colitis (UC). It is a complex surgery with 
potential complications, and the functional outcomes can be worse over time. So, it 
is essential to select the appropriate patient, proceed to a correct surgical technique, 
and know-how to deal with and solve the main ileal pouch complications. This 
chapter intends to be a reflection on this subject.
Keywords: restorative proctocolectomy, ileal pouch-anal anastomosis,  
ileal-anal pouch complications, ileal-anal pouch failure, ileal-anal pouch results, 
familial adenomatous polyposis, ulcerative colitis, Crohn’s disease
1. Introduction
Restorative proctocolectomy with ileal pouch-anal anastomosis (RPC-IPAA) is 
a complicated colorectal surgical procedure. It is mainly used to treat patients with 
familial adenomatous polyposis (FAP) and ulcerative colitis (UC). It is also per-
formed to treat selected patients with Crohn’s disease (CD), indeterminate colitis, 
and synchronous colorectal cancer (CRC) [1]. Among these pathologies, ulcerative 
colitis is the primary postoperative histopathological diagnosis, as Fazio data show, 
in 2013 [2].
IPAA surgery, first described by Parks and Nicholls in 1978 [3], aims to defini-
tively cure disease and prevent malignant degeneration while providing adequate 
continence and avoiding a permanent stoma.
The majority of patients experience long-term success but are not absent from 
significant surgical complications. The main ones are pelvic sepsis, pouchitis, pouch 
failure, fecal incontinence, female infertility, and sexual dysfunction. Others, 
like stenosis, pouch dysplasia/cancer, IPAA prolapse, preileal IPAA pouchitis, and 
anemia, are rare [4].
IPAA results depend on several factors, such as the pathology underlying and 
specific features, gender, age, IBM, patient comorbidities, surgical techniques, and 
surgeon experience.
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So, before to propose or avoid RPC with IPAA, there are aspects to take into 
account:
• What is the underlying pathology, and if the RPC indication is absolute or 
relative;
• if the patient needs a total proctocolectomy or if it is possible to spare part of 
the rectum;
• rule out the presence of relative or absolute contraindication for IPAA and also,
• evaluation of all elements that increase the risk of IPAA failure.
2.  Indications for proctocolectomy: the underlying pathology and 
specific features
There is specific colorectal pathology that, during its natural development, 
requires a colectomy or a proctocolectomy, with or without restorative gest. Let us 
analyze the characteristics of the different underlying pathology and how they can 
influence the surgical decision.
2.1 Familial adenomatous polyposis
FAP is an inherited disease classically characterized by the development of 
hundreds to thousands of adenomas in the rectum and colon during the second 
decade of life (Figure 1). A less aggressive variant of FAP is the so-called attenuated 
FAP (aFAP), where the rectum is frequently spared.
Although FAP is responsible for less than 1% of colorectal malignancies, untreated 
individuals with FAP carry a 100% risk of colorectal cancer by 40–50 years.
Thus, for patients with FAP, the single way to prevent colorectal cancer is surgery.
Nowadays, it is widely accepted that RPC-IPAA is the procedure of choice to 
treat patients with classical FAP.
We can choose for aFAP, total abdominal colectomy with ileorectal anastomosis 
(TAC-IRA), or proctocolectomy with stapled ileal pouch distal rectal anastomosis 
(CP-IPDRA).
FAP highlights:
• young population; absolute indication for surgery; if present rectal involve-
ment, proctocolectomy is required; higher risk of desmoid in some family; 
RPC-IPAA is the procedure of choice to treat patients with classical FAP; RPC-
IPAA easier in FAP than in UC [5].
Figure 1. 
Familial adenomatous polyposis – colon details.
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2.2 Ulcerative colitis
UC is a chronic inflammatory condition characterized by continuous mucosal 
inflammation of the colon and rectum.
Nowadays, surgery is required in a limited number of patients with UC, either in 
an elective or in an emergency setting.
In patients with UC and indication for surgery, RPC is widely considered the 
gold standard surgical procedure. However, TAC-IRA is justified for some particu-
lar cases.
Emergent colectomy in UC is indicated in acute severe UC, not responding 
to medical therapy, or when complications occur such as severe bleeding, toxic 
megacolon, and colon perforation [6].
2.2.1 Acute severe ulcerative colitis, not responding to medical therapy
Acute UC is considered severe when the patient has at least 10 stools per day, 
tachycardia, fever, anemia, and increased erythrocyte sedimentation rate (ERS)/C 
reactive protein (CRP). The severity of ulcerative colitis classification by Truelove 
and Witts distinguishes acute severe ulcerative colitis from fulminant ulcerative 
colitis [7]. All authors do not recognize this division, but it makes it possible to 
infer the probability of failure with corticosteroid therapy and the need for a total 
colectomy (Table 1).
Acute severe UC, not responding to medical therapy, is one of the few cases that 
require emergent colectomy in UC. As shown in the management of flowchart in 
ASUC situations (Figure 2), about 30% of cases do not respond to corticosteroid 
therapy, and 50% of the ASUC will require surgery during the following year [8].
According to Saha et al., the policy of early colectomy, within 7 days, in patients 
with ASUC who fail to respond to intensive steroid-based therapy improves periop-
erative outcomes with significantly low inhospital mortality and morbidity [9].
Disease severity Features
Slight <4 stools/day with +/− blood,
normal ESR,
Without sepsis signs
Mild 4–6 stools/day with occasional blood loss,
minimal signs of sepsis,
CRP ≤30 mg/L
Severe ≥6 bloody stools/day with any of the following parameters:
• temperature > 37.8°C
• tachycardia > 90 ppm
• anemia, Hgb < 10.5 g/dL
• ERS > 30 mm/h,
• CRP > 30 mg/L
Fulminant 10 stools/day with continued bleeding,
abdominal distension and tenderness,
need of blood transfusions,
toxic megacolon in X-ray.
CRP = C reactive protein; ERS = erytrocyte sedimentation rate; Hgb = hemoglobin.
Table 1. 
Ulcerative colitis severity classification. Adapted from Truelove and Witts criteria.
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On the other hand, when complications occur in severe ASUC, such as severe 
bleeding, toxic megacolon, and perforation, emergency surgery is mandatory. In 
these particular situations, the timing of colectomy is of utmost importance to 
reduce the postoperative complication rates.
2.2.2 Complications of acute severe ulcerative colitis
Severe bleeding, toxic megacolon, and perforation are the main complications of 
ASUC (Figures 3 and 4).
They are rare, but their presence increases surgery morbidity and mortality. If 
the UC surgery is urgent or emergent, the decision to perform surgery should be 
made in a multidisciplinary team, including the gastroenterologist and colorectal 
surgeon. In those cases, surgery is usually performed in three-step. Total colectomy, 
the first step, is made in an emergency room. The other steps electively, after 
confirmed diagnosis in the resected specimen.
2.2.3 Chronic refractory UC
Elective RPC for UC is indicated in chronic refractory UC (Figure 5) and also in 
the presence of high-grade dysplasia (HGD) or colorectal malignancies.
The introduction of biologic therapy has added further complexity to medi-
cal management decisions, surgery, and the relative timing of these choices. 
Appropriate medical management of UC may induce and maintain remission and 
may prevent surgery. However, medical management also carries risks of adverse 
effects, and recent data suggest that delay of surgery during ineffective medical 
therapy can increase the chances of adverse surgical outcomes. To make individual-
ized, timely treatment decisions, early collaboration between gastroenterologists 
and surgeons is essential, and more data on predictors of treatment response and 
Figure 2. 
Management of flowchart in acute severe ulcerative colitis.
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positive outcomes are needed. Early identification of patients who would benefit 
from biologic therapy or surgery is challenging, and the definition of chronic refrac-
tory ulcerative colitis (CRUC) difficult. In CRUC (Figure 4), several therapeutic 
Figure 3. 
Severe bleeding in acute severe ulcerative colitis not a responder to corticosteroids and infliximab. Surgery was 
performed in the emergency room.
Figure 4. 
X-ray and surgical specimen of toxic megacolon reports. There are more frequent in extensive ulcerative colitis 
than in ulcerative proctosigmoiditis. Surgical mortality is 1–8% that rises to 40% in colon perforation with 
peritonitis.
Figure 5. 
Endoscopic images of chronic refractory ulceratice colitis.
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options have already been tried, such as infliximab, adalimumab, cyclosporine, 
azathioprine with 6-mercaptopurine, tacrolimus, or fecal transplantation, without 
success. When the therapeutic side effects are unbearable, or despite treatment, the 
patient has no quality of life, and RPC with IPAA may be the best solution.
2.3 Presence of high-grade dysplasia or colorectal malignancies
The presence of high-grade dysplasia (HGD) or colorectal cancer is another 
indication for elective RPC with IPAA in IC.
Colorectal surveillance in UC obeys specific rules (Figure 6) [10], and chromo-
endoscopy has an essential role in dysplasias identification (Figure 7) [11, 12]. In 
UC surveillance, the chromoendoscopy allows to split the cases in visible dysplasia 
and invisible dysplasia (Figure 7) [13, 14].
Nowadays, dysplasia management in UC takes into account the grade and 
number of dysplasia, whether visible or not, and the presence of primary sclerosing 
cirrhosis (PSC) (Figures 8 and 9) [11, 15, 16].
Figure 7. 
Role of chromoendoscopy in dysplasia endoscopic visiblility.
Figure 6. 
Colorectal surveillance in UC (33 biopsies allow 90% accuracy in dysplasia diagnosis).
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Figure 8. 
Management of visible dysplasia in ulcerative colitis.
Figure 9. 
Management of invisible dysplasia in ulcerative colitis.
Risk factor Magnitude of the 
risk
References
Primary sclerosing cholangitis OR: 4.0 Soetikno RM et al. Gastrointestinal Endoscoc 2002 [19]
Disease duration
Cumulative incidence 20 years 2.5–8.0% Eaden et al. [20]
Cumulative incidence 30 years 7.5–18.0% Lakatos PL et al. World J Gastroenterol [21]
Extent of inflammation
Pancolitis SIR: 5.1–14.8 Eaden et al. [20]
Left-sided colitis SIR: 2.1–2.8 Soderlund S et al. Gastroenterology 2009 [22]
Pseupolyposis OR: 2.1–2.5 Velayos FS et al. World J Gastroenterol. 2013 [23]
Rutter MD et al. Gut. 2004 [24]
Family history of CRC RR: 2.4–9.2 Velayos FS et al. World J Gastroenterol. 2013 [23]
Rutter MD et al. Gut. 2004 [24]
Degree of inflammation
Endoscopy OR: 2.5 Rutter MD et al. Gut. 2004 [24]
Histology OR: 5.1
Table 2. 
CRC risk factors in ulcerative colitis.
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In a systematic review of the literature, Fumery et al. found that among 
patients with UC-LGD under surveillance, the annual incidence of progression 
to CRC was 0.8%. Concomitant primary sclerosing cholangitis, invisible dyspla-
sia, distal location, and multifocal LGD are high-risk features associated with 
dysplasia progression [17].
In UC patients with high-grade dysplasia or colorectal cancer (CRC), the colon 
and rectum should be removed with en bloc oncologic resection of lymph nodes 
in all colonic segments due to the high risk of multiple synchronous tumors and 
preoperative under staging (ECCO statement 9A) [18].
The risk of colorectal cancer in UC is increased compared with the general 
population (Table 2) [19–24]. Moreover, it is estimated to be around 18% after 
30 years of UC duration [20].
Occasionally, total abdominal colectomy with ileorectal rectal anastomosis 
(TAC-IRA) can be considered.
2.4 Colitis in Crohn disease
Some of the patients with an acute severe colitis inaugural picture have inde-
terminate colitis or Crohn colitis. When they indicate emergency surgery, the 
first step is the colectomy. The realization of an elective restorative proctectomy 
with an IPAA must be individually analyzed. Patients with CD after IPAA, when 
compared with UC, have a fivefold higher risk of failure, twofold risk of strictures, 
and a sixfold risk of fistulae. This risk is much higher if the diagnosis is performed 
only after IPAA. However, function in those who retain the pouch seemed similar 
to that of patients with UC. CD does not increase the risk of pouchitis. IPAA 
could be offered to a selected population of CD patients after proper preoperative 
counseling (Figure 10).
Ileal pouch rectal anastomosis seems to be another viable alternative to perma-
nent ileostomy in Crohn’s proctocolitis patients. IPRA offers durable preservation 
Figure 10. 
Nine years after IPAA in a patient with Crohn’s disease.
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of bowel continuity and proper function and quality of life (QOL) in selected CC 
patients who might otherwise require a permanent ileostomy [25].
3. When the rectum can be partially spare
When the rectum can be partially spare, total abdominal colectomy with 
ileorectal anastomosis (TAC-IRA), a less complicated colorectal surgical procedure 
than RCP-IPAA, is an option. These solutions must be considered in attenuated 
familial adenomatous polyposis (aFAP) and synchronous colorectal cancer, and 
infrequently in UC and Crohn’s disease.
The assessment of the rectum state is a parameter to consider when the 
surgical plan procedure is made. In FAP, behind the number of polyps present in 
the rectum (less than 10), the aggressiveness and development of extracolonic 
symptoms of the disease are other aspects to take into account. The mutation site 
on the APC gene is associated with the FAP phenotype, including desmoid tumor 
(DT) development. The more distal the mutation (closer to 3′ end), the higher 
the risk of the patient being affected by the desmoid tumor [1, 9, 17]. Typical 
disease symptoms were observed in families who harbored mutations between 
exon 4 (codon 169) and codon 1393 of exon 15. Mutations beyond codon 1403 
were associated with a more varied phenotype concerning the development of 
extracolonic symptoms, namely desmoid tumor (DT). Their presence is related 
to aggressiveness disease and usually dictates the outcome of the patient. Despite 
the possibility of DT arising in any location, DT related to FAP is mostly on the 
abdominal region: intra-abdominal, on the abdominal wall, and transabdominal. 
Some of them take a benign course, with slow evolution, stabilization of growth, 
or even remission. Others show aggressive behavior with rapid growth and mass 
effect on surrounding structures, particularly in intra-abdominal DT. Possible 
complications of intra-abdominal DT are intestinal obstruction, ischemia, 
hemorrhage, and perforation or ureteric obstruction [1, 4, 8]. When DT develops 
in FAP patients, they can be the reason for the pouch failure case, and they are 
the second most common cause of mortality [20].
In synchronous CRC, the rectal tumor stage and location define the surgery to 
perform. If the rectum can be spare, TAC-AIR is the choice. RPC-IPAA with total 
mesorectum excision and with or without neoadjuvant chemoradiotherapy may be 
the solution in selected patients with medium or distal rectal cancer, depending on 
if the tumor is localized or locally advanced.
In IBD with proctocolitis involvement, rectum spare is controversial, mainly is 
ulcerative colitis. The decision-based in the absence of activity in the rectal mucosa.
4. When the rectum cannot be spare
When the rectum cannot be spare, it is mandatory to rule out the presence of 
relative or absolute contraindication for IPAA. There are absolute contraindica-
tions for IPAA: They are the presence of poor anal sphincter function with fecal 
incontinence in all pathologies, the distance between the tumor and pectin line 
inferior to 1 cm or sphincter involvement in distal rectal cancer, and the presence of 
perianal disease beyond proctocolitis in Crohn disease. The aggressive phenotype in 
FAP, indeterminate proctocolitis, and Crohn’s disease, with involvement limited to 
the colon and rectum, are the relative contraindications. Morbid obesity increased 
technical difficulties and can be considered a relative contraindication, as the 
willingness in young women to get pregnant.
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4.1  Evaluation of factors that increase the risk of IPAA failure when rectum 
cannot be spared
RCP with IPAA is, in fact, a complicated colorectal surgical procedure even 
in the hands of experienced high-volume surgeons. In an extensive series of 1789 
patients undergoing proctocolectomy, IPAA was attempted but abandoned intraop-
eratively in 4.1% [26].
So, the relative indication for that type of elective surgery must be carefully con-
sidered. Several aspects must take into account for surgery plan mainly in UC cases:
• the pathology underlying and specific features;
• if the surgery is elective or urgent;
• patient age;
• patient comorbidities;
• patient anal sphincter and rectum status;
• and the experience of the surgeon.
Moreover, weigh the risk and frequency of IPAA morbidity and the patient is will 
after informed consent, which are also factors that influence the surgical decision.
5. Surgical alternatives to IPAA after a proctocolectomy/total colectomy
RPC-IPAA is “the gold standard” procedure to treat patients with classical FAP 
and elective surgery in UC, although other surgical solutions are possible (Table 3).
Operation Advantages Disadvantages
Rectal mucosectomy with 
ileal pouch-anal canal
Anastomosis
Complete excision of large 
intestinal disease




At risk for pouchitis
Nocturnal fecal spotting present
Stapled ileal pouch-distal
rectal anastomosis




At risk for pouchitis and cancer from 
residual rectal mucosa





Intubation of pouch required
At risk for pouchitis and need for valve 
revision
Brooke ileostomy Complete excision of large 
intestinal disease
One operation
Stoma present, risk of parastomal hernia
Incontinent for feces
Need of external appliance
Ileorectal anastomosis Transanal defecation and 
fecal continence preserved
No ileostomy
Diseased rectum remains to produce 
symptoms, require treatment, and 
predispose to cancer
Table 3. 
Bowel transit reconstruction types after a proctocolectomy/total colectomy.
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6.  IPAA surgical procedure and technical aspects that interfere in pouch 
results
RPC-IPAA is a complex procedure that pouch results also depend on technical 
surgical details and surgeon experience.
6.1 RPC-IPAA procedure
RPC with IPAA is a procedure that can be made in one, two, or three stage, by 
laparoscopic or open surgery.
The laparoscopic approach, if feasible, allows better cosmetics and outcomes.
One-stage or two-stage procedure is recommended for elective surgery and 
three-stage for emergent surgery.
Stage 1—An ileal pouch is made, and anastomosed to the anus is made after de 
proctocolectomy without a protective ileostomy. The operation is made in elective 
surgery and completed in a single stage (one surgery).
Stage 2—After a PC and IPAA confection, the anastomosis is protected by a loop 
ileostomy, and ileostomy closure is posterior realized (two surgeries).
Stage 3—At the emergency room, the first step is the total abdominal colectomy 
and ileostomy. The second step is the IPAA with the anastomosis protected by a loop 
ileostomy. The third surgery is the ileostomy closure (three surgeries).
Due to anastomotic complications (infection, fistulization, development 
of Crohn’s disease, disease recurrence, or poor function), an ileostomy may be 
required (stage 2) to prevent complications or if the pouch fails postoperatively. The 
authors are not unanimous about the need to do a derivative ileostomy by routine 
during IPAA construction (stage 1 vs. stage 2).
Lovegrove et al. found to be associated with ileostomy omission: stapled anasto-
mosis (odds ratio [OR], 6.4), no preoperative corticosteroid use (OR, 3.2), familial 
adenomatous polyposis diagnosis (OR, 2.6), cancer diagnosis (OR, 3.4), female sex 
(OR, 1.6), and age at surgery younger than 26 years (OR, 2.1) (p < 0.01 for all). They 
are convinced that incorporating a five-point nomogram in the preoperative assess-
ment of patients undergoing RPC might help clinicians identify a select group of 
patients who may be candidates for ileostomy omission during RPC [27]. Karjalainen 
et al. showed in their study that a diverting ileostomy is associated with considerable 
morbidity, and it does not seem to prevent later failure of the pouch. Therefore, they 
suggest that a diverting ileostomy should only be constructed for high-risk patients 
[28]. On the other hand, Rottoli et al. demonstrated that closure of ileostomy after 
three-stage IPAA is associated with a low rate of serious complications, despite the 
higher number of previous abdominal surgeries, supporting the construction of 
routine ileostomy during IPAA to reduce the risk of pelvic sepsis [29].
6.2 IPAA pouch confection
The most used pouch configurations are the J-pouch and de S-pouch, wherein 
most centers opt for J-pouch. S-pouch is usually reserved for patients with high 
IBM, short mesentery, or handsewn anastomosis necessity. Wu et al. recommend 
using an S-pouch when constructing an IPAA with a handsewn technique. A total 
of 502 patients included 169 patients with an S-pouch (33.7%). The frequencies 
of short-term complications in the two groups were similar (p > 0.05), but pouch 
fistula or sinus (p = 0.047), pelvic sepsis (p = 0.044), postoperative partial small-
bowel obstruction (p = 0.003), or postoperative pouch-related hospitalization 
(p = 0.021) occurred in fewer patients with an S-pouch. At a median follow-up 
of 12.2 (range, 4.3–20.1) years, patients with an S-pouch were found to have 
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fewer bowel movements (p < 0.001), less frequent pad use (p = 0.001), and a 
lower fecal incontinence severity index score (p = 0.015). The pouch failed in 
62 patients (12.4%), but neither univariate nor multivariate analysis showed a 
significant association with pouch configuration IPAA surgery stage [30].
6.3  IPAA-mucosectomy vs. anal transactional zone mucosa and handsewn vs. 
stapled anastomosis
The IPAA can be made with transanal mucosectomy and handsewn anastomosis 
or preserving the anal transitional zone mucosa in a small rectal cuff and stapled 
anastomosis.
Dafni et al. refer that stapled IPAA and younger age at the onset of UC correlated 
with better functional results, and the HRQOL scores were high [31].
Kirat et al. studied the influence of stapler size used at IPAA on the anastomotic 
leak, stricture, long-term functional outcomes, and quality of life. They analyzed 
the stapled IPAA performed between 1983 and 2007: A (stapler size 28–29 mm) 
(n = 1.221) and B (stapler 31–33 mm) (n = 899). They did not found a significant 
difference in rates of leak (4.5% vs. 6.2%, p = 0.08) or stricture (1.9% vs. 2.7%, 
p = 0.1) for groups A and B. There was no significant association between the size of 
the stapler used at IPAA and long-term complications [32].
7.  Main surgical complications in restorative proctocolectomy with ileal 
pouch anal anastomosis (RPC-IPAA)
Surgical complications in RPC with IPAA are not unusual as functional dete-
rioration of pouch and quality of life (QOL). Fazio et al. encountered in their data 
early perioperative complications in 33.5% of patients with a mortality rate of 0.1%. 
On the other hand, he refers to good functional outcomes and QOL in 95% [2]. 
Nevertheless, these results by Fazio, mainly the functional outcomes of the IPAA, 
are not reached in all centers, probably depending on the surgeon experience and 
the high patient volume. The most leading and frequent IPAA complications are 
described as follows:
7.1 Pelvic sepsis
Pelvic sepsis occurs in 9% of the procedure, and its presence increases the risk 
of pouch failure. Pelvic sepsis is a common early complication with far-reaching 
consequences of long-term pouch dysfunction, but prompt intervention (either 
radiological or surgical) reduces the risk of pouch failure. According to Lavryk et 
al., 4031 patients who underwent IPAA in 1983–2014 (patients with Crohn’s disease 
or cancer were excluded), 357 (8.8%) developed IPAA-related pelvic sepsis with or 
without anastomotic dehiscence [33].
7.2 Acute pouchitis
The inflammation of the IPAA can appear in acute (60%) or chronic (60%) form.
Kayal et al. state 53% that acute pouchitis occurred in 205 patients (53%), 60 of 
whom (30%) progressed to chronic pouchitis [34].
Hashavia et al. followed prospectively 201 UC patients who underwent IPAA 
(1981–2009 for a mean of 108 months). A total of 138 (69%) of these had either a regu-
lar pouch or episodes of acute pouchitis and 63 (31%) developed chronic pouchitis [35].
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7.3 Pouch failure rate
Pouch failure rates range from 5.5 to 8.5%, depending upon the length of follow-
up [36]. In Fazio data, 3707 patients underwent primary pouch, and 328 (8.1%) redo 
pouch surgery (primary surgery in other centers). Pouch failure occurred in 197 
(5.5%) of the 3707. During a median follow-up of 84 months, 119 patients (3.2%) 
required excision of the pouch, 32 (0.8%) had a nonfunctioning pouch, and 46 
patients (1.2%) had redo IPAA [2].
7.4 Fecal incontinence: mild – 17%; severe – 3.7%
Mild fecal incontinence is a common complication of IPAA and seems to worsen 
with time [37].
Mild and severe fecal incontinence during the day: 17 and 3.7% of patients, 
respectively.
(Incontinence during the night: 13.1 and 4.5%; urge incontinence during the 
day: 7.3%).
At 12 months post-IPAA, it has been reported that 19% of patients suffered 
occasional daytime incontinence, and 49% suffered nocturnal incontinence [7]. 
Consequently, this can have a significantly negative impact on the quality of life of 
patients. The evidence to support the use of SNS for fecal incontinence after IPAA 
remains very limited.
7.5 Female infertility
Studies have shown that fertility in women with UC is comparable to the back-
ground population but drops following restorative proctocolectomy [38].
This problem can be restricted, opting for a laparoscopic approach and using in 
vitro fertilization.
Laparoscopy was associated with a significantly reduced time to conceive 
compared with the open approach [39].
Females with RPC for UC have an increased incidence of in vitro fertilization 
by more than a factor of three. The odds that a treatment results in live birth are 
similar, and six times more children are born due to in vitro fertilization compared 
with females without restorative proctocolectomy [40].
7.6 Sexual dysfunction: 1.5–4%
Sexual dysfunction can appear after RCP with IPAA. Postoperative impotence 
and retrograde ejaculation have been observed in approximately 1.5–4% of men, 
respectively. Transient dyspareunia occurs in about 7% of women [41].
7.7 Pouch dysplasia/cancer: 1%
About 1% of patients develop dysplasia or carcinoma after surgery, which occurs 
in the retained rectum, anal transitional zone, or ileal pouch, depending upon the 
procedure performed.
Mark-Christensen et al. analyzed 1723 patients with IPAA operated for ulcerative 
colitis in the period 1980–2010 that matched to 8615 individuals from the back-
ground population. They concluded that pouch cancer following IPAA is sporadic, 
questioning the need for general, rather than selective, surveillance. The overall 
cancer risk is comparable to that of the background population (Figure 11).  
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The increased risk of hepatobiliary cancer is likely an effect of coexisting liver 
disease and not causally related to IPAA [42].
8. Conclusion
RCP with IPAA in the hands of experienced high-volume surgeons is a safe 
procedure associated with good functional results, provided that the risk-benefit is 
appropriately weighted.
9. Take-home messages
• RPC with IPAA is the golden standard procedure for FAP and selected UC 
when the rectum cannot be spared, and the patient has a normal anal sphincter 
function.
• RPC with IPAA can also be performed in some patients with indeterminate 
colitis, Crohn’s disease, and synchronous CRC.
• IPAA has morbidity and functional results that worsen with time, mainly if the 
underlying pathology is Crohn’s disease or indeterminate colitis.
To propose an RPC with IPAA, it is necessary:
• to confirm a normal anal sphincter function and the need for total 
proctocolectomy;
• know the underlying pathology and specific features;
• assess the risk of pouch morbidity and disfunction taking into account beyond 
the underlying pathology:
 ○ patient age, gender, IBM, and comorbidities.
 ○ indication for the surgery.
 ○ the time between the onset of the disease and surgery.
 ○ experience of the center in RPC with IPAA and patient’s will.
Figure 11. 
Nine years passed between RCP with IPAA for FAP. The residual polyps were appearing in IPAA, easily 
handled by endoscopic surveillance with polypectomy.
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